Abstract
A possible loss in kidney charge permselectivity of proteins before any manifestation of nephropathy has been sought in type 2 (non-insulin-dependent) diabetes by assessing the clearances of proteins differing in charge and/or size (anionic and cationic immunoglobulins, albumin). Eighty-five consecutive outpatients with type 2 diabetes were studied and compared with 101 normal subjects. Of the patients, 14.1% wree microalbuminuric and 2.3% macroalbuminuric. A significant increase in protein clearances was observed in diabetic patients in comparison with normal subjects: the median of albumin clearance was 0.09 ml/min, interquartile range (IR) 0.04–0.31 (P<0.01 vs normals); that of anionic immunoglobulins (IgG4) 0.02 ml/min, IR 0.01–0.05 (P<0.005 vs normals); and that of neutral/cationic immunoglobulins (IgG) 0.13 ml/min, IR 0.07–0.19 (P<0.01 vs normals). The anionic/cationic immunoglobulin ratio median was 0.22, IR 0.11–0.43, and exceeded the upper limit of normal values in 29.4% of all patients. IgG4 clearance was positively correlated with albumin clearance (r=0.72) and with IgG clearance (r=0.98). Nevertheless anionic immunoglobulin clearance was increased in a number of patients (17.3%) with normal IgG excretion and even in patiens (15.1%) with normal albumin clearance. Clearances of IgG4 and IgG, but not that of albumin, were correlated with the duration of diabetes. Thus, an increased anionic/cationic IgG ratio in type 2 diabetes highlights a charge selectivity defect in protein permselectivity; this selective proteinuria may reflect more accurately than does microalbuminuria an early kidney abnormality in this form of diabetes.
Similar content being viewed by others
References
Klein JD, Brown DM, Oegema TR, Glomerular proteoglycans in diabetes: partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats. Diabetes 35:1130, 1986
Kanwar YS, Rosenzweig W, Linker A, Jakubowski ML, Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci USA 80:2272, 1983
Cohen MP, Surma ML, [35S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes. J Lab Clin Med 98:715, 1981
Wu V-Y, Wilson B, Cohen MP, Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes. Diabetes 36:679, 1987
Viberti G, Mackintosh D, Keen H, Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus. Diabetes 32 [Suppl 2]:92, 1983
Myers BD, Winetz JA, Chui F, Michaels AS, Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function. Kidney Int 21:633, 1982
Kverneland A, Feldt-Rasmussen B, Vidal P, Welinder B, Bent-Hansen L, Soegaard U, Deckert T, Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29:634, 1986
Kverneland A, Welinder B, Feldt-Rasmussen B, Deckert T, Improved metabolic control does not alter the charge-dependent glomerular filtration of albumin in uncomplicated type 1 (insulin-dependent) diabetes. Diabetologia 31:708, 1988
Viberti GC, Keen H, The patterns of proteinuria in diabetes mellitus: relevance to pathogenesis and prevention of diabetic nephropathy. Diabetes 33:86, 1984
Deckert T, Feldt-Rasmussen B, Mathiesen ER, Baker L, Pathogenesis of incipient nephropathy: a hypothesis. Diabetic Nephropathy 3:83, 1984
Vernier LR, Steffes MW, Sisson-Ross S, Mauer SM, Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 41:1070, 1992
Nakamura Y, Myers BD, Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 37:1202, 1988
Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M, Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33:100, 1988
Di Mario U, Morano S, Cancelli A, Bacei S, Frontoni S, Pietravalle P, Gambardella S, Andreani D, New parameters to monitor the progression of diabetic nephropathy. Am J Kidney Dis 13:45, 1989
Pietravalle P, Morano S, Cristina G, De Rossi MG, Mariani G, Cotroneo P, Ghirlanda G, Clementi A, Andreani D, Di Mario U, Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance. Diabetes 40:1685, 1991
Mogensen CE, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310:356, 1984
Jarrett RJ, Viberti GC, Argyropulos A, Microalbuminuria predicts mortality in non-insulin-dependent diabetic subjects. Diabetic Med 1:17, 1984
Tung P, Levin SR, Nephropathy in non-insulin-dependent diabetes mellitus. Am J Med 85 [Suppl 5A]:131, 1988
Hotta O, Taguma Y, Mitsuoka M, Takeshita K, Takahashi H, Urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus in an early microalbuminuric stage. Nephron 58:23, 1991
Di Mario U, Pietravalle P, Napoli A, Morano S, Mancuso M, Gambardella S, Andreani D, A sensitive routine assay for urinary albumin based on the competitive binding to anti-albumin antibodies in solid phase. Horm Metab Res 18:689, 1986
Morano S, Cancelli A, Mancuso M, Sensi M, Negri M, Gambardella S, Di Mario U, Sensitive immunoenzymatic assay for urinary immunoglobulins of different pH: its significance in diabetic patients. diabetes Res 6:181, 1987
Di Mario U, Morano S, Mancuso M, Pietravalle P, Napoli A, Gambardella S, Andreani D, Urinary immunoglobulin G: a routine and highly sensitive technique based on competitive binding. J Clin Lab Immunol 20:255, 1986
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Kofoed-Enevoldsen A, Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219, 1989
Dennis VW, Robinson RR, Proteinuria. In: Seldin DW, Giebisch G (eds) The kidney: physiology and pathophysiology. Raven Press, New York, 1805, 1985
Sumpio BE, Maack T, Kinetics competition and selectivity of tubular absorption of proteins. Am J Physiol 243:F379, 1982
Christensen EL, Rennke HG, Carone FA, Renal tubular uptake of protein: effect of molecular charge. Am J Physiol 243:F379, 1982
Reddi AS, Camerini-Davalos RA, Diabetic nephropathy: an update. Arch Intern Med 150:31, 1900
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morano, S., Pietravalle, P., De Rossi, M.G. et al. A charge selectivity impairment in protein permselectivity is present in type 2 diabetes. Acta Diabetol 30, 138–142 (1993). https://doi.org/10.1007/BF00572857
Issue Date:
DOI: https://doi.org/10.1007/BF00572857